Track the Indoco Remedies Limited share price and the full insider trade history of the company, a publicly traded company based in India. Shares are listed on the IN market, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Indoco Remedies Limited has recorded 62 reports. Market capitalisation: €20.2bn. The latest transaction was reported on 30 December 2025 (Purchase). Among the most active insiders: MADHURA SURESH KARE. The full history is free.
62
Insider Decl.
n/a
Thresholds
€1m
54 ops.
Buy Volume
€438,848
8 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Indoco Remedies Limited Hold (neutral), based on 4 analysts. Average price target: ₹264.00.
10Σ signal
Buys €1m€438,848 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,684 of 28,803 companies
34.3
score / 100
Value
36
Quality
33
FCF yld5.0%
Earn yld-4.7%
EV/EBITDA21.9x
ROE-10%
Gross mgn70%
Net mgn-5.3%
Debt/EBITDA7.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
9,150 shares@ ₹270.5621.3% of flowEquity SharesSEBI:08d5439531fb7cb75d2afbfd06cb07685fc31245
25 of 62 declarations
About Indoco Remedies Limited
Indoco Remedies Limited is an Indian pharmaceutical company focused on the manufacturing of generic drugs and formulations. It primarily operates in the Indian market and also exports its products to several countries.